Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EBT (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBT data on record, last reported at $50.8 million in Q4 2025.

  • For Q4 2025, EBT rose 18.44% year-over-year to $50.8 million; the TTM value through Dec 2025 reached $114.2 million, up 939.52%, while the annual FY2025 figure was $98.5 million, 804.74% up from the prior year.
  • EBT reached $50.8 million in Q4 2025 per TECH's latest filing, up from $48.0 million in the prior quarter.
  • Across five years, EBT topped out at $103.7 million in Q3 2022 and bottomed at -$133.1 million in Q2 2024.
  • Average EBT over 5 years is $39.9 million, with a median of $48.8 million recorded in 2023.
  • Peak YoY movement for EBT: surged 274.12% in 2022, then tumbled 449.32% in 2024.
  • A 5-year view of EBT shows it stood at $86.2 million in 2021, then dropped by 22.92% to $66.4 million in 2022, then plummeted by 49.74% to $33.4 million in 2023, then grew by 28.42% to $42.9 million in 2024, then rose by 18.44% to $50.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $50.8 million in Q4 2025, $48.0 million in Q3 2025, and -$22.9 million in Q2 2025.